Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Headache and Migraine
Allergan Comments on the United States Department of Justice Subpoena for the Production of Documents Relating to Promotional Practices of BOTOX(R) for Therapeutic Uses
March 22nd, 2008
Allergan, Inc. (NYSE: AGN) announced that it received a subpoena from the United States Department of Justice, United States Attorney's Office for the Northern District of Georgia requesting the production of documents regarding promotional practices involving BOTOX(R) (botulinum toxin type A) for therapeutic indications. The subpoena broadly requests documents regarding promotional, educational and other activities relating to BOTOX(R). Allergan's current understanding is that the inquiry involves questions regarding alleged off label promotion relating to the use of BOTOX(R) for the treatment of headache. While Allergan is currently in phase III clinical studies...
Source: Law & Health Weekly (2008-03-22)
|
